|
Market Closed -
Sao Paulo
15:13:53 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 188.29 BRL | -.--% |
|
-.--% | +16.95% |
| 09-04 | Eisai, Biogen Secure China's Nod for Self-Injection Version of Leqembi | MT |
| 09-03 | Piper Sander Adjusts Biogen Price Target to $245 From $225, Maintains Overweight Rating | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.87% | +3.58% | +5.53% | +30.26% | +7.24% | +44.36% | +0.30% | +23.76% | +106.99% | 82.65B | |
| -0.76% | -0.17% | +27.92% | +72.94% | -0.36% | -19.38% | -36.49% | -44.69% | +65.85% | 60.24B | |
| -2.23% | +3.71% | +145.99% | +206.81% | +393.56% | +478.96% | +34.33% | -66.65% | - | 58.11B | |
| +1.31% | -3.43% | -5.78% | +9.40% | -13.51% | -7.43% | +31.70% | +0.37% | - | 49.68B | |
| -0.14% | -2.32% | -5.74% | -19.43% | -11.86% | +1.64% | +153.86% | +116.05% | +185.54% | 46.66B | |
| -1.64% | +1.93% | +6.20% | +13.05% | +25.48% | +56.98% | -15.50% | -32.52% | -29.29% | 32.63B | |
| -0.98% | +2.86% | +5.13% | +23.80% | +28.33% | +46.30% | +99.76% | +69.68% | +53.73% | 25.69B | |
| -1.63% | -2.02% | +2.31% | +35.90% | +30.56% | -0.95% | +159.92% | +55.55% | - | 22.73B | |
| -1.06% | +0.04% | -0.71% | +0.76% | +35.22% | +62.93% | +104.73% | +83.90% | +336.47% | 16.54B | |
| -0.87% | -6.99% | -6.23% | +11.82% | -17.29% | -21.81% | +774.82% | +429.25% | +6,501.63% | 14.92B | |
| -0.76% | -2.28% | -11.41% | +10.69% | -2.16% | +40.20% | +159.59% | +44.81% | - | 14.63B | |
| +0.15% | +1.99% | +4.26% | +17.19% | +11.95% | +15.16% | -26.42% | -14.50% | -30.80% | 12.88B | |
| -0.80% | +4.11% | -2.85% | -11.04% | +13.16% | +65.12% | +153.84% | +678.46% | +2,659.41% | 10.83B | |
| -3.56% | -0.31% | +9.74% | +19.02% | +45.31% | +138.40% | +195.60% | +504.52% | - | 10.6B | |
| -3.10% | -10.27% | +7.82% | +80.18% | +293.19% | +384.16% | +432.76% | +9.07% | - | 7.82B | |
| -0.79% | -0.16% | -3.53% | +8.37% | -8.26% | -20.20% | -19.87% | -52.92% | -49.48% | 6.88B | |
| -1.40% | +0.28% | -0.82% | +26.64% | +1.54% | -7.69% | +75.57% | -13.55% | - | 6.21B | |
| -3.18% | -0.92% | +2.43% | +60.90% | +88.87% | +118.17% | +356.15% | +520.80% | - | 6.08B | |
| -0.62% | -1.64% | -10.76% | +10.08% | +1.99% | -1.37% | +225.94% | +196.22% | - | 5.63B | |
| Average | -1.26% | -0.67% | +8.92% | +31.97% | +48.58% | +72.29% | +150.56% | +131.98% | +980.00% | 25.86B | |
| Weighted average by Cap. | -1.08% | +0.56% | +20.95% | +45.28% | +57.67% | +81.94% | +82.31% | +56.31% | +492.05% |
- Stock Market
- Stocks
- BIIB Stock
- BIIB34 Stock
- Sector Biogen Inc.
Select your edition
All financial news and data tailored to specific country editions
